Skip to main content
Tallo logoTallo logo

Find Jobs

Find Jobs Near You – Available Work in Your Location

Skip to job details
Apply for this opportunity

To apply for this job, you'll continue to an external website or email application.

Legend Biotech

Sr. Manager, Biostatistician / Programmer

Career Insights for Biostatistics Manager / Director

See where this job fits in the broader career landscape. Knowing your career path helps you see what's possible from here.

Scorecard

Based on New Jersey data

Review key factors to help you decide if this role fits your goals. How is this calculated?

Were these scores useful?

What they do

A Biostatistics Manager or Director manages a team of statisticians and directs statistical analysis and reporting of health and biology-related data. Analysis may be used for product development at a pharmaceutical company, disease research at a hospital or health policy research at a public health organization. Directs the design of statistical analysis and reviews analysis and findings; may manage regulatory reporting for projects such as clinical trials.

$186,796 / year median in New Jersey

Explore Career

Job Description

Sr. Manager, Biostatistician / Programmer Employer Legend Biotech Location Somerset, New Jersey Start date Jul 15, 2026 View more categories View less categories Discipline Information Technology , Applications/Technical Support , Science/R D , Biostatistics Required Education Masters Degree/MBA Position Type Full time Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Send job Job Details Company Job Details Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide. Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma. Legend Biotech is seeking a Sr. Manager, Biostatistician/Programmer as part of the Clinical team based in Somerset, NJ . Role Overview The Sr. Manager, Biostatistician/Programmer plays a critical hands-on role in supporting Legend Biotech's clinical development programs by transforming clinical trial data into high-quality analyses, tables, figures, and listings that inform decision-making. This role partners closely with clinical, translational, research stakeholders to deliver timely insights, conduct exploratory and ad hoc analyses, and deeply understand the medical and scientific questions underlying the data. The position requires strong programming expertise, data agility, intellectual curiosity, and the ability to work independently in a fast-moving biotech environment. Key Responsibilities Develop, validate, and maintain high-quality Tables, Figures, and Listings (TFLs) to support ongoing clinical trials, interim analyses, and internal/external deliverables in compliance with study requirements and standards. Perform hands-on statistical programming and data manipulation to support planned and ad hoc analyses, addressing evolving clinical and scientific questions. Independently explore and interrogate clinical trial data to identify trends, anomalies, and insights that support clinical interpretation and decision-making. Collaborate closely with Biostatistics, Clinical Development, Clinical Operations, Data Management, Translational research and Medical teams to ensure alignment of analyses with protocol objectives and clinical intent. Apply a strong understanding of therapeutic area, disease biology, and clinical endpoints to translate data into meaningful scientific insights. Contribute to analysis datasets, program specifications, programming documentation, and quality control activities in accordance with internal standards and regulatory expectations. Support process improvement initiatives, including enhancing programming efficiency, standardization, and reproducibility across studies and programs. This role operates with a high degree of autonomy in determining programming approaches, exploratory analyses, and data interrogation strategies to answer clinical questions. The Sr. Manager may independently make decisions related to analysis methods, programming solutions, prioritization of tasks, and investigative follow-up of data issues. Escalation and alignment are expected for changes impacting study-level strategy, major deliverables, timelines with external visibility, or regulatory-facing outputs. Requirements Master's degree or PhD in Statistics, Biostatistics, Mathematics, Data Science, or a related quantitative discipline. Demonstrated hands-on experience developing TFLs and performing ad hoc and exploratory analyses for clinical trials. Strong understanding of clinical trial design, clinical data structures, and the medical context behind analyses. Proven ability to work independently, manage ambiguity, and drive self-directed discovery from data. Experience supporting oncology and/or cell therapy programs is strongly preferred. Advanced proficiency in SAS for clinical trial analysis and reporting. Working knowledge of R for exploratory analyses and data visualization Strong experience with clinical data standards (e.g., SDTM, ADaM) Experience with or strong willingness to leverage AI-assisted programming tools to accelerate development, enhance code quality, and support efficient generation of Tables, Figures, and Listings (TFLs). #Li-LB1 #Li-Hybrid Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech. EEO Statement It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances. Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company. For information related to our privacy notice, please review: Legend Biotech Privacy Notice . Company Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap. For two years, Legend Biotech, then known as the "Legend Project," operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies. In 2015, Legend's scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China. In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world.
CARVYKTI
™ (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022. Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies. Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies. Company info Location Somerset New Jersey United States Share this job Facebook Twitter LinkedIn Apply now Send job Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Get job alerts Create a job alert and receive personalized job recommendations straight to your inbox. Create alert Similar jobs Senior EDC Lead North Chicago, IL Biostatistical Programming Manager Washington D.C., District of Columbia Global Head of Clinical Data and Business Strategy Morristown, New Jersey